Heart Failure with Preserved Ejection Fraction Viewed as a Systemic Inflammatory-Metabolic Condition: Insights from the Cardio-Hepato-Pancreatic Axis - Report - MDSpire
Advertisement
Heart Failure with Preserved Ejection Fraction Viewed as a Systemic Inflammatory-Metabolic Condition: Insights from the Cardio-Hepato-Pancreatic Axis
Clinical Report: Heart Failure with Preserved Ejection Fraction as a Systemic Condition
Overview
Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized as a systemic inflammatory-metabolic condition rather than solely a myocardial disorder. This shift in understanding highlights the role of the cardio-hepato-pancreatic axis in disease progression and management.
Background
HFpEF accounts for approximately half of all heart failure cases and is rising in prevalence. Traditional therapeutic approaches have not yielded significant benefits, prompting a reevaluation of the underlying mechanisms of HFpEF. Recognizing HFpEF as a systemic disease may lead to more effective treatment strategies targeting its multifactorial nature.
Data Highlights
No specific numerical data provided in the source material.
Key Findings
HFpEF is associated with obesity, diabetes, and systemic inflammation.
Chronic hepatic congestion may actively contribute to HFpEF progression.
Pancreatic exocrine insufficiency is common in HFpEF and may worsen outcomes.
Metabolic dysfunction–associated steatotic liver disease (MASLD) is a significant contributor to systemic inflammation in HFpEF.
Adipokines secreted by dysfunctional adipose tissue are linked to HFpEF pathophysiology.
Clinical Implications
Clinicians should consider the systemic nature of HFpEF when developing treatment plans, focusing on managing comorbidities such as obesity and diabetes. Early intervention with SGLT2 inhibitors and addressing pancreatic involvement may improve patient outcomes.
Conclusion
Understanding HFpEF as a systemic inflammatory-metabolic condition opens new avenues for treatment and management, emphasizing the importance of a comprehensive approach to patient care.
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
